VERAXA Biotech GmbH
In December 2020, Veraxa Biotech AG, Zurich, Switzerland, was incorporated toacquire Araxa Biosciences GmbH, Heidelberg, Germany, and Velabs TherapeuticsGmbH, Heidelberg, Germany. Araxa Biosciences GmbH was incorporated in January2019 and Velabs Therapeutics GmbH in 2017, both spin-off companies from theEuropean Molecular Biology Laboratory (EMBL) in Heidelberg and its technology transfer arm EMBLEM Technology Transfer GmbH. In 2021, Araxa Biosciences GmbH and Velabs Therapeutics GmbH merged to become Veraxa Biotech GmbH, which isfully owned by the Swiss entity Veraxa Biotech AG. Veraxa Biotech AG operates through Veraxa Biotech GmbH.